|Articles|August 28, 2019
The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing
Author(s)Thermo Fisher Scientific
ORC International’s report Implications of Inaccurate Forecasting on Biologics Drug Substance Manufacturing explores causes, consequences, and potential solutions to forecasting challenges related to biopharmaceutical drug substance manufacturing. It provides insight and perspective on key themes that emerge from the report, offering additional solutions to prepare for inevitable forecast inaccuracies.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Integrating AI Discovery, Continuous Manufacturing, and Modern Regulatory Hurdles into Pharma Production
2
Pharma Industry Uncertainty in Wake of On/Off Greenland Tariffs
3
The Shift from Containment to Protection: Packaging Trends Impacting Pharma
4
FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use
5